Oxis Turbuhaler (formoterol), Accolate (zafirlukast) or placebo as add on treatment to Pulmicort Turbuhaler (budesonide) in asthmatic patients on inhaled steroids

Authors
Category Primary study
Registry of TrialsAstraZeneca
Year 1998
OBJECTIVES: The primary objective of the study was to assess the efficacy of Oxis (formoterol) 9 mg b.i.d., and Accolate (zafirlukast) 20 mg b.i.d. as add on treatments to Pulmicort (budesonide) Turbuhaler 200 mg b.i.d in asthmatics not adequately controlled on inhaled GCS. The primary variable for the analysis of efficacy was the change in morning PEF. Secondary variables were FEV1, asthma exacerbations and diary card data.
Epistemonikos ID: 41c1054acfbe8476c85ef055929cc6968d75ca7d
First added on: Nov 13, 2014